Invitation to comment on the new ‘In Hospital Management of Glycaemia’ recommendations 22 May 2023 The Living Evidence for Diabetes Consortium is a collaboration between Diabetes Australia, the Australian Diabetes Society (ADS), the Australian Diabetes Educators Association (ADEA) and the Australia and New Zealand Society for Paediatric Endocrinology and Diabetes (ANZSPED), with representation from the Royal Australian College of General Practitioners (RACGP) and Cochrane Australia. The Consortium has developed a series of new evidence based clinical recommendations regarding the In Hospital Management of Glycaemia. About the consultation Public consultation will run from Friday, 12th of May to Monday, 12th of June 2023. Late submissions will not be accepted. Where to find the new recommendations The new recommendations can be found on the ADS website here: https://www.diabetessociety.com.au/living-evidence-guidelines-in-diabetes/ Content of submissions Submissions may include identified issues, suggested improvements, or whether or not you support the recommendations. If you do not support the recommendation(s), please provide reasons and propose suitable amendments. How to respond Comments can be submitted via email to project coordinator Dr Tanya Millard at [email protected]. The Consortium will provide due consideration to all comments received, and a summary of submissions and the actions taken will be provided following consultation.